Expanding the Spectrum of GLI1-rearranged Neoplasms of the Gastrointestinal Tract to Include Monophasic Keratin-positive Epithelial Neoplasms.
Journal
The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904
Informations de publication
Date de publication:
01 Nov 2024
01 Nov 2024
Historique:
medline:
25
10
2024
pubmed:
25
10
2024
entrez:
25
10
2024
Statut:
ppublish
Résumé
GLI1-altered tumors form a diverse group occurring in various anatomic locations. In the alimentary tract, the most established are gastroblastoma, a biphasic epithelial-mesenchymal neoplasm of the stomach, and plexiform fibromyxoma, a pure spindle cell neoplasm. The spectrum of GLI1-rearranged gastrointestinal tumors has recently expanded with reports of cases in other parts of the GI tract, some exhibiting gastroblastoma-like features and others being pure mesenchymal neoplasms. These tumors often display a nonspecific immunophenotype, with only CD56 and cyclin D1 expression being common. Biphasic GLI1-altered tumors show diffuse keratin positivity in the epithelial component only, and GLI1-altered mesenchymal tumors typically lack or show only focal keratin expression. This study details 2 GLI1-rearranged gastrointestinal tract tumors with diffuse keratin and CD56 expression, composed entirely of epithelial cells with a nested growth pattern and finely stippled monotonous nuclei, leading to an initial suspicion of neuroendocrine tumor in both cases, despite lack of synaptophysin and chromogranin expression. Diffuse strong nuclear cyclin D1 expression was seen in both cases, and conversely, strong cyclin D1 staining was only seen in 5.4% (4/74) of well-differentiated neuroendocrine tumors tested. These 2 GI tract neoplasms highlight a widened spectrum of GLI1-rearranged tumors, now including monophasic epithelial neoplasms with diffuse keratin expression.
Identifiants
pubmed: 39451014
doi: 10.1097/PAS.0000000000002303
pii: 00000478-202411000-00006
doi:
Substances chimiques
Zinc Finger Protein GLI1
0
Biomarkers, Tumor
0
GLI1 protein, human
0
Keratins
68238-35-7
Types de publication
Journal Article
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1389-1394Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Références
Agaram NP, Zhang L, Sung YS, et al. GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions. Mod Pathol. 2019;32:1617–1626.
Cloutier JM, Kerr DA. GLI1-altered mesenchymal tumors. Surg Pathol Clin. 2024;17:13–24.
Machado I, Hosler GA, Traves V, et al. Superficial GLI1-amplified mesenchymal neoplasms: expanding the spectrum of an emerging entity which reaches the realm of dermatopathology. J Cutan Pathol. 2023;50:487–499.
Palsgrove DN, Rooper LM, Stevens TM, et al. GLI1-altered soft tissue tumors of the head and neck: frequent oropharyngeal involvement, p16 immunoreactivity, and detectable alterations by DDIT3 break apart FISH. Head Neck Pathol. 2022;16:1146–1156.
Liu J, Mao R, Lao IW, et al. GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity. Virchows Arch. 2022;480:1087–1099.
Ichikawa D, Yamashita K, Okuno Y, et al. Integrated diagnosis based on transcriptome analysis in suspected pediatric sarcomas. NPJ Genom Med. 2021;6:49.
Castro E, Cortes-Santiago N, Ferguson LM, et al. Translocation t(7;12) as the sole chromosomal abnormality resulting in ACTB-GLI1 fusion in pediatric gastric pericytoma. Hum Pathol. 2016;53:137–141.
Ambrosio M, Virgilio A, Raffone A, et al. Malignant epithelioid neoplasm of the ileum with ACTB-GLI1 fusion mimicking an adnexal mass [published correction appears in BMC Womens Health. 2022 May 25;22(1):188]. BMC Womens Health. 2022;22:104.
Zeng Y, Yao H, Jiang X, et al. GLI1-altered mesenchymal tumor involving the duodenum: case report and literature review. Int J Surg Pathol. 2023;31:1538–1547.
Kerr DA, Cloutier JM, Margolis M, et al. GLI1-altered mesenchymal tumors with ACTB or PTCH1 fusion: a molecular and clinicopathologic analysis. Mod Pathol. 2024;37:100386.
Argani P, Boyraz B, Oliva E, et al. GLI1 gene alterations in neoplasms of the genitourinary and gynecologic tract. Am J Surg Pathol. 2022;46:677–687.
Hui L, Bai Q, Yang W, et al. GLI1-rearranged mesenchymal tumor in the ovary. Histopathology. 2022;81:688–692.
Antonescu CR, Agaram NP, Sung YS, et al. A distinct malignant epithelioid neoplasm with GLI1 gene rearrangements, frequent S100 protein expression, and metastatic potential: expanding the spectrum of pathologic entities with ACTB/MALAT1/PTCH1-GLI1 fusions. Am J Surg Pathol. 2018;42:553–560.
Papke DJ Jr, Dickson BC, Oliveira AM, et al. Distinctive nested glomoid neoplasm: clinicopathologic analysis of 20 cases of a mesenchymal neoplasm with frequent GLI1 alterations and indolent behavior. Am J Surg Pathol. 2023;47:12–24.
Dahlén A, Fletcher CD, Mertens F, et al. Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am J Pathol. 2004;164:1645–1653.
Spans L, Fletcher CD, Antonescu CR, et al. Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma. J Pathol. 2016;239:335–343.
Graham RP, Nair AA, Davila JI, et al. Gastroblastoma harbors a recurrent somatic MALAT1-GLI1 fusion gene. Mod Pathol. 2017;30:1443–1452.
Koo SC, LaHaye S, Kovari BP, et al. Gastroblastoma with a novel EWSR1-CTBP1 fusion presenting in adolescence. Genes Chromosomes Cancer. 2021;60:640–646.
Chen C, Lu J, Wu H. Case report: submucosal gastroblastoma with a novel PTCH1::GLI2 gene fusion in a 58-year-old man. Front Oncol. 2022;12:935914.
Shabbir J, Earle J, Glomski K, et al. Gastroblastoma with a novel ACTB::GLI1 gene fusion in a 19-year-old male. Virchows Arch 2024;484:859–864.
McCammon N, Dunn A, Graham R, et al. Gastroblastoma of the pylorus: a case report and review of the literature. Int J Surg Pathol. 2023;31:1516–1521.
Banerjee S, Corless CL, Miettinen MM, et al. Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma. J Transl Med. 2019;17:246.
Prall OWJ, McEvoy CRE, Byrne DJ, et al. A malignant neoplasm from the jejunum with a MALAT1-GLI1 fusion and 26-year survival history. Int J Surg Pathol. 2020;28:553–562.
Jessurun J, Orr C, McNulty SN, et al. GLI1-rearranged enteric tumor: expanding the spectrum of gastrointestinal neoplasms with GLI1 gene fusions. Am J Surg Pathol. 2023;47:65–73.
Bahceci DH, Grenert JP, Jordan RCK, et al. Genomic profiling of the craniofacial ossifying fibroma by next-generation sequencing. Head Neck Pathol. 2023;17:722–730.
Parrack PH, Mariño-Enríquez A, Fletcher CDM, et al. GLI1 immunohistochemistry distinguishes mesenchymal neoplasms with GLI1 alterations from morphologic mimics. Am J Surg Pathol. 2023;47:453–460.